Cargando…

Impact of the Severity of Alzheimer’s Disease on the Quality of Life, Activities of Daily Living, and Caregiving Costs for Institutionalized Patients on Anti-Alzheimer Medications in Japan

BACKGROUND: Alzheimer’s disease (AD) increases societal costs and decreases the activities of daily living (ADL) and quality of life (QoL) of the affected individuals. OBJECTIVE: We assess the impact of AD severity on ADL, QoL, and caregiving costs in Japanese facilities for the elderly. METHODS: Pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ashizawa, Takumi, Igarashi, Ataru, Sakata, Yukinori, Azuma, Mie, Fujimoto, Kenichi, Kobayashi, Tsukasa, Takase, Yoshimasa, Ikeda, Shunya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203217/ https://www.ncbi.nlm.nih.gov/pubmed/33780368 http://dx.doi.org/10.3233/JAD-201514

Ejemplares similares

Improvement in prescriptions while maintaining overall health outcomes: a prospective observational study conducted in Japanese facilities for older people
por: Ashizawa, Takumi, et al.
Publicado: (2022)

Economic Burden of Alzheimer’s Disease Dementia in Japan
por: Ikeda, Shunya, et al.
Publicado: (2021)

Predicting the Societal Value of Lecanemab in Early Alzheimer’s Disease in Japan: A Patient-Level Simulation
por: Igarashi, Ataru, et al.
Publicado: (2023)

Linguistic and Psychometric Validation of the Cognition Bolt-On Version of the Japanese EQ-5D-5L for the Elderly
por: Igarashi, Ataru, et al.
Publicado: (2023)

Cost-effectiveness analysis of lemborexant for treating insomnia in Japan: a model-based projection, incorporating the risk of falls, motor vehicle collisions, and workplace accidents
por: Ikeda, Shunya, et al.
Publicado: (2022)

Cost-effectiveness analysis of lemborexant for treating insomnia in Japan: A model-based projection, incorporating the risk of falls, motor vehicle collisions, and workplace accidents – CORRIGENDUM
por: Ikeda, Shunya, et al.
Publicado: (2022)

Predictors of Institutionalization in Patients with Alzheimer's Disease in South Korea
por: Park, Dong-Gyu, et al.
Publicado: (2018)

Institutionalization risk and costs associated with agitation in Alzheimer's disease
por: Cloutier, Martin, et al.
Publicado: (2019)

Association Between Activities of Daily Living and Mortality Among Institutionalized Elderly Adults in Japan
Publicado: (2012)

WTP for a QALY and health states: More money for severer health states?
por: Shiroiwa, Takeru, et al.
Publicado: (2013)

Costs and Resource Use Associated with Community-Dwelling Patients with Alzheimer’s Disease in Japan: Baseline Results from the Prospective Observational GERAS-J Study
por: Nakanishi, Miharu, et al.
Publicado: (2020)

An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D
por: Feng, Yan, et al.
Publicado: (2017)

Emotional Distress in the Relationship of Caregivers and Institutionalized Babies
por: do Nascimento, Rosemeire Aparecida, et al.
Publicado: (2020)

Development of multivariable prediction models for institutionalization and mortality in the full spectrum of Alzheimer’s disease
por: Mank, Arenda, et al.
Publicado: (2022)

Family caregiving in dementia and its impact on quality of life and economic burden in Japan-web based survey
por: Igarashi, Ataru, et al.
Publicado: (2020)

Health state utilities of patients with hepatitis B and C and hepatitis-related conditions in Japan
por: Sugimori, Hiroki, et al.
Publicado: (2022)

Detection, diagnosis, and treatment of Alzheimer’s disease dementia stratified by severity as reported by caregivers in Japan
por: Montgomery, William, et al.
Publicado: (2018)

Caregiving in Alzheimer’s and Other Dementias
por: Horien, Corey
Publicado: (2016)

COVID-19 Lockdown Effect on Not Institutionalized Patients with Dementia and Caregivers
por: Moretti, Rita, et al.
Publicado: (2021)

Health-Related Quality of Life during COVID-19 Pandemic: Assessing Impacts of Job Loss and Financial Support Programs in Japan
por: Ikeda, Takaaki, et al.
Publicado: (2021)

Cost-effectiveness analysis of lenvatinib treatment for patients with unresectable hepatocellular carcinoma (uHCC) compared with sorafenib in Japan
por: Kobayashi, Masahiro, et al.
Publicado: (2019)

Challenges of Caregivers of Patients With Alzheimer’s Disease
por: Sajwani, Zara
Publicado: (2020)

Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D
por: Shiroiwa, Takeru, et al.
Publicado: (2015)

Caregiver burden and coping strategies in caregivers of patients with Alzheimer’s disease
por: Iavarone, Alessandro, et al.
Publicado: (2014)

Comparison of the Effects of a Brand-name Drug and Its Generic Drug on the Quality of Life of Alzheimer’s Disease Patients
por: Sakakibara, Mikio, et al.
Publicado: (2015)

Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias in African Americans: Focus on Caregivers
por: Kopel, Jonathan, et al.
Publicado: (2023)

Oral health care activities performed by caregivers for institutionalized elderly in Barcelona-Spain
por: Cornejo-Ovalle, Marco, et al.
Publicado: (2013)

Prevalence of stress, anxiety and depression in with Alzheimer caregivers
por: Ferrara, Maria, et al.
Publicado: (2008)

Neuropsychiatric Symptoms of Alzheimer's Disease and Caregiver Burden
por: Iravani, Behnam, et al.
Publicado: (2022)

Informal Caregiving and Alzheimer’s Disease: The Psychological Effect
por: Hellis, Emily, et al.
Publicado: (2022)

Experiences of caregiving with Alzheimer’s disease in the LGBT community
por: Candrian, Carey, et al.
Publicado: (2023)

Burden of illness associated with pneumococcal infections in Japan - a targeted literature review
por: Igarashi, Ataru, et al.
Publicado: (2021)

The transdermal formulation of rivastigmine improves caregiver burden and treatment adherence of patients with Alzheimer's disease under daily practice conditions
por: Adler, G, et al.
Publicado: (2014)

USE OF FDA-APPROVED ALZHEIMER’S DISEASE MEDICATIONS AMONG NON-INSTITUTIONALIZED U.S. ADULTS AGE 60 YEARS AND OLDER
por: Frenk, Steven, et al.
Publicado: (2019)

Trends in prevalence of self-reports of Alzheimer’s disease/dementia among non-institutionalized individuals 45+ in Canada, 1994–2014
por: Chambers-Richards, Tamara, et al.
Publicado: (2022)

Association between sleep disturbance in Alzheimer’s disease patients and burden on and health status of their caregivers
por: Okuda, Shoki, et al.
Publicado: (2019)

Feasibility and effectiveness of a cosmetic intervention program for institutionalized older women in Japan
por: Hayakawa, Yohko, et al.
Publicado: (2016)

Estimated Quality-Adjusted Life-Year Associated with the Degree of Activities of Daily Living in Patients with Alzheimer's Disease
por: Kasai, Mari, et al.
Publicado: (2013)

Institutionalized Discontent
por: Gilbert, Neil
Publicado: (2016)

Alzheimer’s disease severity and its association with patient and caregiver quality of life in Japan: results of a community-based survey
por: Montgomery, William, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1gconfrq3dppsvt91376jp9v96